Distribution of Drug-Resistant Genes Among Thai Multidrug-Resistant Mycobacterium Tuberculosis (MDR-TB) Clinical Isolates
Keywords:
No KeywordAbstract
No Abstract
References
1. World Health Organization. Global tuberculosis control: surveillance, planning, financing: WHO report 2009.
2. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung
Dis. 1998;79(1):3-29.
3. Prammananan T, Cheunoy W, Taechamahapun D, Yorsangsukkamol J, Phunpruch S, Phdarat P, Leechawengwongs M, Chaiprasert A. Distribution
of rpoB mutations among multidrug-resistant Mycobacterium tuberculosis (MDRTB) strains from Thailand and development of a rapid
method for mutation detection. Clin Microbiol Infect. 2008 May;14(5):446-53.
4. Timmins GS, Deretic V. Mechanisms of action of isoniazid. Mol Microbiol. 2006 Dec;62(5):1220-7.
5. Boonaiam S, Chaiprasert A, Prammananan T, Leechawengwongs M. Genotypic analysis of genes associated with isoniazid and ethionamide
resistance in MDR-TB isolates from Thailand. Clin Microbiol Infect. 2010 Apr;16(4):396-9
6. Zhang Y, Mitchison D. The curious characteristics of pyrazinamide: a review. Int J Tuberc Lung Dis. 2003 Jan;7(1):6-21.
7. Lemaitre N, Sougakoff W, Truffot-Pernot C, Jarlier V. Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuber
culosis and identification of conserved regions important for the catalytic activity of pyrazinamidase Pnc. Antimicrob Agents Chemother. 1999
Jul;43(7):1761-3.
8. Rienthong S, Rienthong D, Smithikarn S, Yamnimnual S. Study of initial drug resistance of pyrazinamide in new pulmonary tuberculosis patients
before treatment in tuberculosis division by detection of enzyme pyrazinamidase. Thai J Tuberc Chest Dis. 1993; 14: 85-89.
9. Pransucharit V, Chuchottaworn C. Detection of initial drug resistance of pyrazinamide in Thai tuberculosis patients by radiometric method.
Thai J Tuberc Chest Dis. 1995; 16: 59-65.
10. Jonmalung J, Prammananan T, Leechawengwongs M, Chaiprasert A. Surveillance of pyrazinamide susceptibility among multidrug-resistant
Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand. BMC Microbiol. 2010 Aug 20;10:223.
2. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung
Dis. 1998;79(1):3-29.
3. Prammananan T, Cheunoy W, Taechamahapun D, Yorsangsukkamol J, Phunpruch S, Phdarat P, Leechawengwongs M, Chaiprasert A. Distribution
of rpoB mutations among multidrug-resistant Mycobacterium tuberculosis (MDRTB) strains from Thailand and development of a rapid
method for mutation detection. Clin Microbiol Infect. 2008 May;14(5):446-53.
4. Timmins GS, Deretic V. Mechanisms of action of isoniazid. Mol Microbiol. 2006 Dec;62(5):1220-7.
5. Boonaiam S, Chaiprasert A, Prammananan T, Leechawengwongs M. Genotypic analysis of genes associated with isoniazid and ethionamide
resistance in MDR-TB isolates from Thailand. Clin Microbiol Infect. 2010 Apr;16(4):396-9
6. Zhang Y, Mitchison D. The curious characteristics of pyrazinamide: a review. Int J Tuberc Lung Dis. 2003 Jan;7(1):6-21.
7. Lemaitre N, Sougakoff W, Truffot-Pernot C, Jarlier V. Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuber
culosis and identification of conserved regions important for the catalytic activity of pyrazinamidase Pnc. Antimicrob Agents Chemother. 1999
Jul;43(7):1761-3.
8. Rienthong S, Rienthong D, Smithikarn S, Yamnimnual S. Study of initial drug resistance of pyrazinamide in new pulmonary tuberculosis patients
before treatment in tuberculosis division by detection of enzyme pyrazinamidase. Thai J Tuberc Chest Dis. 1993; 14: 85-89.
9. Pransucharit V, Chuchottaworn C. Detection of initial drug resistance of pyrazinamide in Thai tuberculosis patients by radiometric method.
Thai J Tuberc Chest Dis. 1995; 16: 59-65.
10. Jonmalung J, Prammananan T, Leechawengwongs M, Chaiprasert A. Surveillance of pyrazinamide susceptibility among multidrug-resistant
Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand. BMC Microbiol. 2010 Aug 20;10:223.
Downloads
Published
03-04-2020
How to Cite
Prammananan, T. . (2020). Distribution of Drug-Resistant Genes Among Thai Multidrug-Resistant Mycobacterium Tuberculosis (MDR-TB) Clinical Isolates. Siriraj Medical Journal, 63(3), 102–105. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/240923
Issue
Section
Special Issue
License
Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:
- Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
